TO STUDY ANALGESIC EFFECT OF 0.25% BUPIVACAINE VS 0.25% ROPIVACAINE IN “3 IN 1” FEMORAL NERVE BLOCK FOR KNEE SURGERIES

Abstract

Background: Total knee replacement (TKR) and other knee surgeries are amongst the most painful orthopedic procedure, mandating effective postoperative pain management. Ropivacaine is a New Local anesthetic Agent With Minimal CVS Toxicity. The primary aim of is to study effect of 3 in 1 femoral Aims: nerve block for providing pain relief with Ropivacaine (0.25%). Secondary aim is to compare the effect of Ropivacaine 0.25% with Bupivacaine( 0.25%) in providing 3 in 1 femoral nerve block. Material and Methods: A prospective randomised study was carried out in 36 ASA I & II patients undergoing knee surgery surgeries were divided into two groups of 18. Group (R) received Ropivacaine (0.25%) 40 ml. Group (B) received Bupivacaine (0.25%) 40 ml. Results: Demographic and hemodynamic parameters were statistically not signicant. The duration of analgesia is longer with Group R (7.83±0.98) than Group B (6.33±0.76) (p<0.001) which is statistically very signicant. Observing VAS score Group R shows signicantly (p<0.05) lower values th th th than Group B for at 4 to 8 hours & than at 24 hour. Ropivacaine is signicantly more effective in postoperative duration of pain. No Adverse events noted in the both groups. Conclusion: Postoperative 3 in 1 femoral nerve block with 0.25% ropivacaine is effective in providing pain relief and duration of analgesia is more in comparison to 0.25% bupivacaine.